
Currently out of the existing stock ratings of Dane Leone, 106 are a BUY (83.46%), 20 are a HOLD (15.75%), 1 are a SELL (0.79%).
Analyst Dane Leone, has had 54.63% of price targets met with an average potential upside of 45.46%, reached in 270 days on average. Previously, Dane Leone worked at RAYMOND JAMES, BTIG.
Dane Leone has documented 232 price targets and ratings displayed on 39 stocks. The coverage was on Healthcare, Technology, Energy, Consumer Cyclical sectors.
Most recent stock forecast was given on RLAY, Relay Therapeutics at 19-May-2026.
Analyst best performing recommendations are on NKTX (NKARTA).
The best stock recommendation documented was for BBIO (BRIDGEBIO PHARMA) on 12/27/2021. The price target of $17 was fulfilled within 7 days with a profit of $5.62 (49.38%), with a performance score of 70.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Aug-2026
$6
$4.96 (476.92%)
$5
3 months 4 days ago
(17-Aug-2026)
1/10 (10%)
$3.92 (188.46%)
148
Sell Since 16-Apr-2026
7 months 5 days ago
(16-Apr-2026)
0/3 (0%)
$2.86 (55.64%)
Buy Since 04-Apr-2023
$11
$9.96 (957.69%)
$12
7 months 5 days ago
(16-Apr-2026)
0/12 (0%)
$8.63 (364.14%)
Hold Since 21-Mar-2023
$3.85
$2.81 (270.19%)
$6
7 months 7 days ago
(14-Apr-2026)
1/2 (50%)
$1.57 (68.86%)
44
Buy Since 14-May-2025
$9
$7.96 (765.38%)
$9
7 months 7 days ago
(14-Apr-2026)
1/4 (25%)
$6.72 (294.74%)
19
Stocks Dane Leone covered previously. Scores are shown for active stocks only.
The record of these past calls is part of the data set at anachart.store.